7,052 Companies

Access all companies

Find technology partners quickly.

Spotfolio tracks over one million companies in technology industries.

There are 7,052 companies in the field of Biotechnology on spotfolio that produce or deliver products, that utilize or research technologies or that are otherwise engaged in topics such as Clinical, Drug, Research, Cell, Scientific, Disease, Molecular, Molecules .

Start-ups (763)

Early-stage companies (1,665)

Established companies (3,854)

The majority of these companies is located in the following countries.

United States (3,553)

United Kingdom (483)

Germany (300)

France (294)

Example Companies

Find companies in your area

Molecules for Health Molecules for Health Inc.

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

- About - Dr. Howard L. Elford - Home - Contact - About molecules for health Molecules for Health, Inc. 800 E Leigh St Suite 206-4 Richmond, 1650 23219 ...

form. Please try again later. Note: Fields marked with * are required Molecules for Health, Inc. 800 E Leigh Street Suite 206-4 Richmond, Virginia 23219 ...

Phone: 804-828-6867 E-mail: mol4hlth@vabiotech.com Print | Sitemap © Molecules for Health, Inc. Login Web ViewMobile View Logout | Edit page

- Home - Contact - About molecules for health Curriculum Vitae Page Under Construction - Dr. Howard L. Elford Molecules for Health, Inc. 800 E Leigh ...

Phone: 804-828-6867 E-mail: mol4hlth@vabiotech.com Print | Sitemap © Molecules for Health, Inc. Login Web ViewMobile View Logout | Edit page

DiCE Molecules DiCE Molecules SV, Inc.

early-stage

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

MEDIA Media Press Releases DiCE Molecules Announces $80 Million Series C Financing January 8, 2021 DiCE Molecules Announces Multi-Year Research Collaboration ...

December 19, 2017 DiCE Molecules Appoints Industry Veteran Richard Scheller to Board of Directors May 11, 2016 Sanofi and DiCE Molecules Announce Research

Immunology Nico Ghilardi, PhD Vice President, Immunology Nico Joined DiCE Molecules in December 2019 as Vice President of Translational Immunology. He spent ...

the immunology space. Under his leadership, several programs advanced molecules into clinical development. Nico has over 25 years of experience in cytokine ...

therapeutic efforts to target important immune cell signaling nodes with small molecules (e.g. JAK1, TYK2, BTK, ITK, NIK, BET, and others). Prior to joining Genentech

Molecules of Man AB

established

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

Molecules of Man Human monoclonal antibodies for treatment or protection against hepatitis C Main menu Skip to primary content Skip to secondary content ...

content - Home Molecules of Man AB Molecules of Man AB is a recent biotech start-up company, spun off from discoveries made at Karolinska Institutet, ...

company. For more information, please contact: Dr. Mats A A Persson Molecules of Man AB Mossvägen 12 167 56 Bromma Sweden E-mail: mats.persson@moleculesofman

Kanaph Therapeutics Kanaph Therapeutics Inc.

start-up

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

Kanaph focuses on the research and development of innovative therapeutic molecules to provide solutions for unmet medical needs in cancer and autoimmune diseases ...

molecule drug discovery efforts include the development of novel small molecules to treat hard-to-cure cancers by targeting specific mutational signaling ...

signaling pathways. We are also taking novel therapeutic approaches with small molecules to remove immuno-suppressive environment created by tumors.

activated immune system will eradicate malignant cancer cells. TMEkine™ molecules are composed of a TME targeting arm and a cytokine arm, the TME targeting ...

formation of lymphoid-like structures Auto-Immune Disease Targeting Large Molecules Specifically inhibiting the alternative pathway of the complement system ...

alternative pathway Cancer-targeting Small Molecules Kanaph is building an oncology portfolio of best-in-class small molecules for areas with high unmet medical

Montisera Montisera Ltd

early-stage

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

Finnish scientific heritage. Montisera takes full advantage of bioactive molecules. The best assets of Finnish university and research institutes turn into ...

cases; ending into pharmaceuticals along with the bioeconomy-based active molecules and natural products. About Find out about our company, mission, our

secures and supports Montisera’s strategy in developing health-promoting molecules from biomass”, says Heikki Vuorikoski, CEO of Montisera. “We have selected

Use detailed technology terms.

Only spotfolio allows for searching with detailed technology terms, as we provide you with all topics that technology companies talk about.

Companies addressing these topics might be of specific interest to you, as they share more specific, niche topics.

Use Cases

Register now

Why Technology Scouting?

Technology scouting is the basis for your innovation management, identifies new technological developments as early as possible and protects you from disruptive business models.

Identify technology partners

Boost your market research

Look beyond major players

Build long and short lists

Collect technology leaders, providers, start ups and potential new partners in lists via simple tagging to take further steps with your team.